UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 718

Sortiert nach

Possible contribution of hyalocytes to idiopathic epiretinal membrane formation and its contraction

British journal of ophthalmology, 2009-08, Vol.93 (8), p.1020-1026

2009

Link zum Volltext

Verfügbarkeit prüfen

Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox

Diabetes (New York, N.Y.), 1999-10, Vol.48 (10), p.1899

1999

Link zum Volltext

Verfügbarkeit prüfen

High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes

Diabetes care, 1999-08, Vol.22 (8), p.1245

1999

Link zum Volltext

Verfügbarkeit prüfen

Regression activity that is naturally present in vitreous becomes ineffective as patients develop proliferative diabetic retinopathy

Diabetologia, 2013-06, Vol.56 (6), p.1444-1453

2013

Link zum Volltext

Verfügbarkeit prüfen

Role of vascular endothelial growth factor in diabetic vascular complications

Kidney international, 2000-09, Vol.58 (S77), p.S113-S119

2000

Link zum Volltext

Verfügbarkeit prüfen

Vascular Endothelial Growth Factor (VEGF)-Induced Retinal Vascular Permeability Is Mediated by Intercellular Adhesion Molecule-1 (ICAM-1)

The American journal of pathology, 2000-05, Vol.156 (5), p.1733-1739

2000

Link zum Volltext

Verfügbarkeit prüfen

Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders

The New England journal of medicine, 1994-12, Vol.331 (22), p.1480-1487

1994

Link zum Volltext

Verfügbarkeit prüfen

Diabetic retinopathy

Diabetes care, 1998-01, Vol.21 (1), p.143

1998

Link zum Volltext

Verfügbarkeit prüfen

Suppression of Retinal Neovascularization in vivo by Inhibition of Vascular Endothelial Growth Factor (VEGF) Using Soluble VEGF-Receptor Chimeric Proteins

Proceedings of the National Academy of Sciences - PNAS, 1995-11, Vol.92 (23), p.10457-10461

1995

Link zum Volltext

Verfügbarkeit prüfen

Vascular Endothelial Growth Factor/Vascular Permeability Factor Expression in a Mouse Model of Retinal Neovascularization

Proceedings of the National Academy of Sciences - PNAS, 1995-01, Vol.92 (3), p.905-909

1995

Link zum Volltext

Verfügbarkeit prüfen

Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth

The Journal of clinical investigation, 1996-11, Vol.98 (9), p.2018-2026

1996

Link zum Volltext

Verfügbarkeit prüfen

Basic fibroblast growth factor induces expression of VEGF receptor KDR through a protein kinase C and p44/p42 mitogen-activated protein kinase-dependent pathway

Diabetes (New York, N.Y.), 1999-05, Vol.48 (5), p.1145

1999

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness of detecting and treating diabetic retinopathy

Annals of internal medicine, 1996-01, Vol.124 (1 Pt 2), p.164

1996

Link zum Volltext

Verfügbarkeit prüfen

Vascular Endothelial Growth Factor and Severity of Nonproliferative Diabetic Retinopathy Mediate Retinal Hemodynamics In Vivo: A Potential Role for Vascular Endothelial Growth Factor in the Progression of Nonproliferative Diabetic Retinopathy

American journal of ophthalmology, 1997-10, Vol.124 (4), p.433-446

1997

Link zum Volltext

Verfügbarkeit prüfen

Hypoxia upregulates glucose transport activity through an adenosine-mediated increase of GLUT1 expression in retinal capillary endothelial cells

Diabetes (New York, N.Y.), 1998-09, Vol.47 (9), p.1480

1998

Link zum Volltext

Verfügbarkeit prüfen

Hypoxia induces vascular endothelial growth factor gene and protein expression in cultured rat islet cells

Diabetes (New York, N.Y.), 1998-12, Vol.47 (12), p.1894

1998

Link zum Volltext

Verfügbarkeit prüfen

Antiangiogenic therapy for ischemic retinopathies

Cold Spring Harbor perspectives in medicine, 2012-06, Vol.2 (6), p.a006411-a006411

2012

Link zum Volltext

Verfügbarkeit prüfen

Preventive eye care in people with diabetes is cost-saving to the federal government. Implications for health-care reform

Diabetes care, 1994-08, Vol.17 (8), p.909

1994

Link zum Volltext

Verfügbarkeit prüfen

Growth factors and protein kinase C inhibitors as novel therapies for the medical management diabetic retinopathy

Eye (London), 2004-02, Vol.18 (2), p.117-125

2004

Link zum Volltext

Verfügbarkeit prüfen

Circulating plasma vascular endothelial growth factor and microvascular complications of Type 1 diabetes mellitus: the influence of ACE inhibition

Diabetic medicine, 2001-04, Vol.18 (4), p.288-294

2001

Link zum Volltext

Verfügbarkeit prüfen

Relation of optical coherence tomography and unusual angiographic leakage patterns in central serous chorioretinopathy

Eye (London), 2008-04, Vol.22 (4), p.592-596

2008

Link zum Volltext

Verfügbarkeit prüfen

Sustained moderate visual loss as a predictive end point for visual loss in non-proliferative diabetic retinopathy

Eye (London), 2009-01, Vol.23 (1), p.209-214

2009

Link zum Volltext

Verfügbarkeit prüfen

Adenosine mediates hypoxic induction of vascular endothelial growth factor in retinal pericytes and endothelial cells

Investigative ophthalmology & visual science, 1996-10, Vol.37 (11), p.2165-2176

1996

Link zum Volltext

Verfügbarkeit prüfen

Hypoxia regulates vascular endothelial growth factor receptor KDR/Flk gene expression through adenosine A2 receptors in retinal capillary endothelial cells

Investigative ophthalmology & visual science, 1996-06, Vol.37 (7), p.1311-1321

1996

Link zum Volltext

Verfügbarkeit prüfen

Randomized trial of peribulbar triamcinolone acetonide with and without focal photocoagulation for mild diabetic macular edema a pilot study

Ophthalmology (Rochester, Minn.), 2007-06, Vol.114 (6), p.1190-1196

2007

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 718

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(633)
Mit Volltextzugriff
(590)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(469)
Life Sciences & Biomedicine
(319)
Humans
(275)
Biological And Medical Sciences
(157)
Female
(155)
Male
(153)
Medical Sciences
(134)
Middle Aged
(118)
Animals
(104)
Physical Sciences
(99)
Adult
(95)
Aged
(87)
Technology
(85)
Physics
(79)
Ophthalmology
(67)
Diabetic Retinopathy
(44)
Adolescent
(39)
Diabetes
(38)
Diabetes. Impaired Glucose Tolerance
(38)
Endocrine Pancreas. Apud Cells
(38)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Possible contribution of hyalocytes to idiopathic epiretinal membrane formation and its contraction

Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox

High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes

Regression activity that is naturally present in vitreous becomes ineffective as patients develop proliferative diabetic retinopathy

Role of vascular endothelial growth factor in diabetic vascular complications

Vascular Endothelial Growth Factor (VEGF)-Induced Retinal Vascular Permeability Is Mediated by Intercellular Adhesion Molecule-1 (ICAM-1)

Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders

Diabetic retinopathy

Suppression of Retinal Neovascularization in vivo by Inhibition of Vascular Endothelial Growth Factor (VEGF) Using Soluble VEGF-Receptor Chimeric Proteins

Vascular Endothelial Growth Factor/Vascular Permeability Factor Expression in a Mouse Model of Retinal Neovascularization

Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth

Basic fibroblast growth factor induces expression of VEGF receptor KDR through a protein kinase C and p44/p42 mitogen-activated protein kinase-dependent pathway

Cost-effectiveness of detecting and treating diabetic retinopathy

Vascular Endothelial Growth Factor and Severity of Nonproliferative Diabetic Retinopathy Mediate Retinal Hemodynamics In Vivo: A Potential Role for Vascular Endothelial Growth Factor in the Progression of Nonproliferative Diabetic Retinopathy

Hypoxia upregulates glucose transport activity through an adenosine-mediated increase of GLUT1 expression in retinal capillary endothelial cells

Hypoxia induces vascular endothelial growth factor gene and protein expression in cultured rat islet cells

Antiangiogenic therapy for ischemic retinopathies

Preventive eye care in people with diabetes is cost-saving to the federal government. Implications for health-care reform

Growth factors and protein kinase C inhibitors as novel therapies for the medical management diabetic retinopathy

Circulating plasma vascular endothelial growth factor and microvascular complications of Type 1 diabetes mellitus: the influence of ACE inhibition

Relation of optical coherence tomography and unusual angiographic leakage patterns in central serous chorioretinopathy

Sustained moderate visual loss as a predictive end point for visual loss in non-proliferative diabetic retinopathy

Adenosine mediates hypoxic induction of vascular endothelial growth factor in retinal pericytes and endothelial cells

Hypoxia regulates vascular endothelial growth factor receptor KDR/Flk gene expression through adenosine A2 receptors in retinal capillary endothelial cells

Randomized trial of peribulbar triamcinolone acetonide with and without focal photocoagulation for mild diabetic macular edema a pilot study

Suchergebnisse filtern